Likes the healthcare area. Cheap compared to the rest of the market. Investors are starting to come into it realizing that negativity towards drug companies had been overdone. Built up a war chest of $3 billion. 5.25% yield.

Swiss company. Market leader globally in electrical distribution transmissions so it is an infrastructure play for both replacement of grids in the developed world as well as in the developing world. Great growth prospects.

Biggest holder of Syncrude, which is increasing production. Stock has been held back because Chevron has announced they are putting their piece of Syncrude up for sale and he expects them to buy into a share issue. Will probably increase their dividend again in the next month.

(A Top Pick Jan 27/09. Up 52.64%.) Company has changed and has become more focused and the upside is great. Still a Buy.

(A Top Pick Jan 27/09. Up 34.54%.) This remains his agricultural play. Still a Buy.

(A Top Pick Jan 27/09. Up 25.12%.) Likes the outlook for drug stocks. Still a Buy.

Had owned because it was a good defensive name with a good yield. When investors started chasing yields, a number of these stocks started getting overvalued and this one started getting expensive. If it comes back down, he may buy it again.